Cargando…
Serine–Arginine Protein Kinase SRPK2 Modulates the Assembly of the Active Zone Scaffolding Protein CAST1/ERC2
Neurons release neurotransmitters at a specialized region of the presynaptic membrane, the active zone (AZ), where a complex meshwork of proteins organizes the release apparatus. The formation of this proteinaceous cytomatrix at the AZ (CAZ) depends on precise homo- and hetero-oligomerizations of di...
Autores principales: | Arancibia, Duxan, Lira, Matias, Cruz, Yocelin, Barrera, Daniela P., Montenegro-Venegas, Carolina, Godoy, Juan A., Garner, Craig C., Inestrosa, Nibaldo C., Gundelfinger, Eckart D., Zamorano, Pedro, Torres, Viviana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912806/ https://www.ncbi.nlm.nih.gov/pubmed/31671734 http://dx.doi.org/10.3390/cells8111333 |
Ejemplares similares
-
Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
por: Caetano, Mônica Maria Magalhães, et al.
Publicado: (2022) -
Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions
por: Xu, Xiaotao, et al.
Publicado: (2017) -
Selective Surface and Intraluminal Localization of Wnt Ligands on Small Extracellular Vesicles Released by HT-22 Hippocampal Neurons
por: Torres, Viviana I., et al.
Publicado: (2021) -
Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
por: Duggan, William P., et al.
Publicado: (2022) -
SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER
por: Mavrou, Athina, et al.
Publicado: (2014)